Animal Health Trust (AHT), Newmarket, UK, www.aht.uk
AHT is an independent trust working within animal health since more than 50 years and has more than 200 employees, including research staff and clinicians. AHT is one of the few institutions in Europe where experimental infections classified as high risk to the environment can be performed. At the Allen Centre facility, Intervacc has tested its prototype vaccines in horses.
The Swedish University of Agricultural Sciences (SLU), Uppsala, www.slu.se
Karolinska Institutet (KI), Stockholm, www.ki.se
Isconova AB, Uppsala, www.isconova.se
Isconova has developed a patented technology that enhances the effect of vaccines (adjuvants). The technique is based on different immune-stimulating components, saponins, which are extracted from the tree Quillaja saponaria. Following purification the immune-stimulating components produce different complexes named iscomes. Iscomes are included in several authorized vaccines amongst one of which is a vaccine against horse influensa. Intervacc has an agreement with Isconova to use the iscome technology in its strangles vaccine.
Nordvacc Läkemedel AB, Stockholm, www.nordvacc.se